Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
DanCann Pharma A/S logo — - a biopharmaceutical company powered by cannabinoids

DanCann Pharma A/S

- a biopharmaceutical company powered by cannabinoids

Founded 2018 Denmark Denmark 11 employees Post-IPO Equity Total: $35.61M Biotechnology, Health and Wellness +2

General Information

Company Name DanCann Pharma A/S
Founded Year 2018
Location Denmark Denmark
Founders / Decision Makers
Team member Team member
Employees 11
Industries Biotechnology, Health and Wellness, Manufacturing +1
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with DanCann Pharma A/S. To contact DanCann Pharma A/S, visit dancann.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does DanCann Pharma A/S compare?

A PDF of DanCann Pharma A/S and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting DanCann Pharma A/S soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About DanCann Pharma A/S

Dancann Pharma is a biopharmaceutical company based in Denmark, focusing on utilizing the potential of cannabinoids in the medical field. Founded in 2018, the company is at the forefront of the intersection between Biotechnology, Manufacturing, and Pharmaceutical industries. In November 2023, Dancann Pharma secured a significant kr1.27MPost-IPO Equity investment, showcasing its growth and potential in the market. With a promising approach to utilizing cannabinoids, Dancann Pharma is positioned to make a notable impact in the biopharmaceutical sector and attract attention from venture capital investors seeking opportunities in innovative medical technologies.

Business keywords: biopharmaceutical, cannabinoids, pharmaceutical research, medical cannabis

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity kr6.94M -
27 Jun 2024
Post IPO Equity kr1.27M -
28 Nov 2023
Post IPO Equity kr500.00K -
04 Oct 2023
Post IPO Debt kr18.90M 1
Nordic Growth
Nordic Growth
02 Jun 2023
Post IPO Equity kr8.00M -
16 May 2023

DanCann Pharma A/S Alternatives & Competitors

View All Alternatives
DanCann Pharma A/S vs
Sanity Group
Sanity Group Germany

Unlocking the potential of cannabinoids to develop innovative pharmaceuticals and consumer health pr...

Convertible Note
104 employees
Biotechnology, Health Care
DanCann Pharma A/S vs
Avicanna Inc. (TSX:AVCN)
Avicanna Inc. (TSX:AVCN) Canada

Driving biopharmaceutical advancements of plant-derived cannabinoid-based products.

Post-IPO Equity
67 employees
Biotechnology, Pharmaceutical
DanCann Pharma A/S vs
Lanthio Pharma
Lanthio Pharma The Netherlands

Biopharmaceutical company discovering and developing stabilized lanthipeptides in oncology and criti...

Debt Financing
1 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About DanCann Pharma A/S

- a biopharmaceutical company powered by cannabinoids
DanCann Pharma A/S was founded in 2018.
DanCann Pharma A/S is headquartered in Denmark.
DanCann Pharma A/S operates in Biotechnology, Health and Wellness, Manufacturing and Pharmaceutical. Its work centres on biopharmaceutical, cannabinoids, pharmaceutical research and medical cannabis.
DanCann Pharma A/S has approximately 11 employees.
DanCann Pharma A/S has completed 5 funding rounds, raising a total of $35.61M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to DanCann Pharma A/S include Sanity Group, Avicanna Inc. (TSX:AVCN), Lanthio Pharma, InMed Pharmaceuticals, Oxford Cannabinoid Technologies Holdings Plc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DanCann Pharma A/S and Sanity Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for DanCann Pharma A/S, https://bouncewatch.com/company/dancann-pharma, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout